CFB
AVNS

Cullen/Frost Bankers’s Avanos Medical AVNS Stock Holding History

Cullen/Frost Bankers’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-16
Closed -$255 – 1294
2024
Q4 		$255 Buy
+16
New +$317 ﹤0.01% 1311
2024
Q2 		– Sell
-37
Closed -$737 – 1240
2024
Q1 		$737 Buy
+37
New +$715 ﹤0.01% 981
2023
Q2 		– Sell
-9
Closed -$268 – 1133
2023
Q1 		$268 Buy
+9
New +$261 ﹤0.01% 1185
2020
Q3 		– Sell
-4,197
Closed -$123K – 1150
2020
Q2 		$123K Buy
+4,197
New +$122K ﹤0.01% 504
2020
Q1 		– Sell
-63
Closed -$2K – 907
2019
Q4 		$2K Hold
63
– – ﹤0.01% 988
2019
Q3 		$2K Buy
+63
New +$2.4K ﹤0.01% 963
2019
Q2 		– Sell
-28
Closed -$1K – 1017
2019
Q1 		$1K Buy
+28
New +$1.25K ﹤0.01% 877

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cullen/Frost Bankers's AVNS Position: Q1 2025 in Review

Cullen/Frost Bankers sold out of Avanos Medical (AVNS) in Q1 2025, closing a stake of 16 shares — an estimated $255 sold.

Cullen/Frost Bankers first reported a position in AVNS in Q1 2019 and held it in 7 quarters. The position peaked at $123K in Q2 2020. 277 funds tracked by Wall St. Rank hold AVNS as of Q1 2025.

  • Cullen/Frost Bankers reported no remaining Avanos Medical position as of Q1 2025 after selling out during the quarter.
  • Cullen/Frost Bankers sold 16 Avanos Medical shares in Q1 2025, an estimated $255.
  • Cullen/Frost Bankers first reported a position in Avanos Medical in Q1 2019 and held it in 7 quarters.
  • Cullen/Frost Bankers's Avanos Medical position peaked at $123K in Q2 2020.
  • 277 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2025.

Based on Cullen/Frost Bankers's 13F filing for Q1 2025, filed 2 May 2025.